Differential expression and release of cytokines by an in vitro reconstructed human epidermis following exposure to skin irritant and sensitizing chemicals

Toxicology in Vitro

Volumn 13, Issue 6, 1999, Pages 867-877

  Coquette, A ^a   Berna, N ^b   Vandenbosch, A ^a   Rosdy, M ^c   Poumay, Y ^b  

^a SGS Medisearch International NV   (Belgium)

^b UNIVERSITY OF NAMUR   (Belgium)

^c SkinEthic   (France)

Author keywords

IL 1; IL 8; Irritation; Keratinocytes; Sensitization

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; INTERLEUKIN 1ALPHA; INTERLEUKIN 8; IRRITANT AGENT; POLYSORBATE 80; TRITON X 100;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; EPIDERMIS; HUMAN; HUMAN CELL; KERATINOCYTE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIZATION; SKIN IRRITATION;

EID: 0032793351     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2333(99)00076-4     Document Type: Article

References (39)

1. Anttila H.S.I., Reitamo S., Erkko P., Ceska M., Moser B., Baggiolini M. Interleukin-8 immunoreactivity in the skin of healthy subjects and patients with palmoplantar pustulosis and psoriasis. Journal of Investigative Dermatology. 98:1992;96-101.
2. Arner E.S.J., Bjornstedt M., Holmgren A. 1-chloro-2,4-dinitrobenzene is an irreversible inhibitor of human thioredoxin reductase-Loss of thioredoxin disulfide reductase activity is accompanied by a large increase in NADPH oxidase activity. Journal of Biological Chemistry. 270:1995;3479-3482.
3. Barker J.N.W.N. Role of keratinocytes in allergic contact dermatitis. Contact Dermatitis. 26:1992;145-148.
4. Barker J.N.W.N., Mitra R.S., Griffiths C.E.M., Dixit V.M., Nickoloff B.J. Keratinocytes as initiators of inflammation. Lancet. 337:1991;211-214.
5. Bell E., Parenteau N., Gay R., Nolte C., Kemp P., Bilbo P., Ekstein B., Johnson E. The living skin equivalent: its manufacture, its organotypic properties and its responses to irritants. Toxicology in Vitro. 5:1991;591-596.
6. Bettley F.R. The toxicity of soaps and detergents. British Journal of Dermatology. 80:1968;635-642.
7. 2TM. Toxicology in Vitro. 10:1996;513-521.
8. Corsini E., Bruccoleri A., Marinovich M., Galli C.L. Endogenous Interleukin-1-alpha is associated with skin irritation induced by tributyltin. Toxicology and Applied Pharmacology. 138:1996;268-274.
9. Corsini E. and Galli C. L. (1997) Use of the in vitro reconstituted human epidermis, EPISKIN, to assess the molecular mechanisms of skin irritation and sensitization. In Animal Alternatives, Welfare and Ethics, ed. L. F. M. Van Zutphen and M. Balls, pp. 575-582. Elsevier, Amsterdam.
10. Corsini E., Shubert C., Marinovich M., Galli C.L. Role of mitochondria in Tributyltin-induced interleukin-1-alpha production in murine keratinocytes. Journal of Investigative Dermatology. 107:1996;720-725.
11. Cumberbatch M., Kimber I. Dermal tumor necrosis factor alpha induces dendritic cell migration to draining lymph nodes and possibly provides one stimulus for Langherhans cell migration. Immunology. 75:1992;257-263.
12. 2TM: An in vitro skin analog. Alternative Methods in Toxicology. 10:1994;121-131.
13. Dickson F.M., Lawrence J.N., Benford D.J. Release of inflammatory mediators in human keratinocyte cultures following exposure to a skin irritant. Toxicology in Vitro. 7:1993;385-388.
14. Doucet O., Robert C., Zastrow L. Use of a serum-free reconstituted epidermis as a skin pharmacological model. Toxicology in Vitro. 10:1996;305-313.
15. Draize J.H., Woodard G., Calvery H.O. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. Journal of Pharmacology and Experimental Therapeutics. 82:1944;377-390.
16. Enk A. H. and Katz S. I. (1992a) Early molecular events in the induction of contact sensitivity. Proceedings of the National Academy of Sciences of the U.S.A. 89, 1398-1402.
17. Enk A.H., Katz S.I. Identification and induction of keratinocyte-derived IL-10. Journal of Immunology. 149:1992;92-95.
18. Gay R., Swiderek M., Nelson D., Ernesti A. The living skin equivalent as a model in vitro for ranking the toxic potential of dermal irritants. Toxicology in Vitro. 6:1992;303-315.
19. Gueniche A., Viac J., Lizard G., Chaveron M., Schmitt D. Effect of different sensitizing haptens on intracellular adhesion molecule-1 expression and cytokine production by normal human keratinocytes. European Journal of Dermatology. 5:1995;320-325.
20. Holliday M.R., Dearman R.J., Corsini E., Basketter D.A., Kimber I. Selective stimulation of cutaneous interleukin 6 expression by skin allergens. Journal of Applied Toxicology. 16:1996;65-70.
21. Ivanyi D., Ansink A., Groeneveld E., Hageman P.C., Mooi W.J., Heintz A.P.M. New monoclonal antibodies recognizing epidermal differentiation-associated keratins in formalin-fixed, paraffin-embedded tissue. Keratin 10 expression in carcinoma of the vulva. Journal of Pathology. 159:1989;7-12.
22. Knop J., Enk A.H. Cellular and molecular mechanisms in the induction phase of contact sensitivity. International Archives of Allergy and Immunology. 107:1995;231-232.
23. Kupper T. Interleukin 1 and other human keratinocytes cytokines in inflammation and functional characterization. Advances in Dermatology. 3:1988;293-308.
24. Magnusson B., Kligman A.M. The identification of contact allergens by animal assay. The guinea pig maximization test. Journal of Investigative Dermatology. 52:1969;268-276.
25. Paludan K., Thestrup-Pedersen K. Use of the polymerase chain reaction in quantification of interleukin 8 mRNA in minute epidermal samples. Journal of Investigative Dermatology. 99:1992;830-835.
26. Ponec M., Kempenaar J. Use of human skin recombinants as an in vitro model for testing the irritation potential of cutaneous irritants. Skin Pharmacology. 8:1995;49-59.
27. Regnier M., Caron D., Reichert U., Schaeffer H. Barrier function of human skin and human reconstructed epidermis. Journal of Pharmaceutical Sciences. 82:1993;404-407.
28. 2TM: an in vitro model to assess cutaneous immunotoxicity. Toxicology in Vitro. 8:1994;1007-1014.
29. Roguet R., Dossou K. G. and Rougier A. (1994) A reconstructed human epidermis to assess cutaneous irritation, photoirritation and photoprotection in vitro. In In Vitro Skin Toxicology: Irritation, Phototoxicity, Sensitization, ed. A. Rougier, A. M. Goldberg and H. I. Maibach, pp. 141-149. Mary Ann Liebert, New York.
30. Rosdy M., Clauss L.C. Terminal epidermal differentiation of human keratinocytes grown in chemically defined medium on inert filter substrates at the air-liquid interface. Journal of Investigative Dermatology. 95:1990;409-414.
31. Rosdy M., Pisani A., Ortonne J.P. Production of basement membrane components by a reconstructed epidermis cultured in the absence of serum and dermal factors. British Journal of Dermatology. 129:1993;227-234.
32. Rowbottom A.W., Norton J., Riches P.G., Sloane J.P. Cytokine gene expression in skin and lymphoid organs in human graft-versus-host disease. Journal of Pathology. 169:1993;150A.
33. Singer E. J. and Pitts E. P. (1985) Surfactants in Cosmetics, ed. M. Rieger, pp. 133-194. Marcel Dekker, New York.
34. Slivka S.R., Laudeen L.L., Zimber M.P., Bartel R.L. Biochemical characterization barrier function and drug metabolism in an in vitro skin model. Journal of Cell Biology. 115:1991;2072.
35. Slivka S.R., Zeigler F. Use of an in vitro skin model for determining epidermal and dermal contributions to irritant response. Journal of Toxicology-Cutaneous and Ocular Toxicology. 12:1993;49-57.
36. 2TM dermal and barrier function models. Life Sciences. 57:1995;215-224.
37. Wang A. M., Doyle M. V. and Mark D. F. (1989) Quantitation of mRNA by the polymerase chain reaction. Proceedings of the National Academy of Sciences of the U.S.A. 86, 9717-9721.
38. Wilmer J.L., Burleson F.G., Kayama F., Kanno J., Luster M.I. Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin. Journal of Investigative Dermatology. 102:1994;915-922.
39. Yang J.J., Krueger A. Evaluation of two commercial human skin cultures for in vitro percutaneous absorption. In Vitro Toxicology. 5:1992;211-217.